Titre (en)
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration SRAS - Analysis (2020)

Index « Titre (en) » - entrée « against »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
again < against < ageing  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 42.
[0-20] [0 - 20][0 - 42][20-40]
Ident.Authors (with country if any)Title
000031 (2020) J. Reina [Espagne][Remdesivir, the antiviral hope against SARS-CoV-2].
000034 (2020) Y. Shi [République populaire de Chine] ; N. Wang [République populaire de Chine] ; Q M Zou [République populaire de Chine][Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)].
000060 (2020) Sergio Rosales-Mendoza [Mexique]Will plant-made biopharmaceuticals play a role in the fight against COVID-19?
000070 (2020) Sergio Rosales-Mendoza [Mexique] ; Ver Nica A. Márquez-Escobar [Mexique] ; Omar González-Ortega [Mexique] ; Ricardo Nieto-G Mez [Mexique] ; Jaime I. Arévalo-Villalobos [Mexique]What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?
000075 (2020) Tuan M. Nguyen [États-Unis] ; Yang Zhang [États-Unis] ; Pier Paolo Pandolfi [États-Unis]Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses.
000077 (2020) Mahmoud Kandeel [Égypte] ; Mohammed Al-Nazawi [Arabie saoudite]Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.
000091 (2020) Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France]Type 1 interferons as a potential treatment against COVID-19
000100 (2020) Chang-Quan LingTraditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2)
000103 (2020) Shan LuTimely development of vaccines against SARS-CoV-2
000132 (2020) Chu-Xia DengThe global battle against SARS-CoV-2 and COVID-19
000185 (2020) Rameez Jabeer Khan [Inde] ; Rajat Kumar Jha [Inde] ; Gizachew Muluneh Amera [Inde] ; Monika Jain [Inde] ; Ekampreet Singh [Inde] ; Amita Pathak [Inde] ; Rashmi Prabha Singh [Inde] ; Jayaraman Muthukumaran [Inde] ; Amit Kumar Singh [Inde]Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase.
000187 (2020) Nathan Ford ; Marco Vitoria ; Ajay Rangaraj ; Susan L. Norris ; Alexandra Calmy ; Meg DohertySystematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment
000196 (2020) Ning Wang [États-Unis] ; Jian Shang [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Lanying Du [États-Unis]Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
000205 (2020) Jacques Fantini [France] ; Coralie Di Scala [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.
000297 (2020) Abdo A. ElfikyRibavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
000330 (2020) Tarek Mohamed Abd El-Aziz [États-Unis, Égypte] ; James D. Stockand [États-Unis]Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
000362 (2020) Jinyong Zhang [République populaire de Chine] ; Hao Zeng [République populaire de Chine] ; Jiang Gu [République populaire de Chine] ; Haibo Li [République populaire de Chine] ; Lixin Zheng [États-Unis] ; Quanming Zou [République populaire de Chine]Progress and Prospects on Vaccine Development against SARS-CoV-2.
000387 (2020) Farid Rahimi [Australie] ; Amin Talebi Bezmin Abadi [Iran]Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat.
000393 (2020) Wen-Hsiang Chen [États-Unis] ; Peter J. Hotez [États-Unis] ; Maria Elena Bottazzi [États-Unis]Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19.
000417 (2020) Guangyu Zhou [République populaire de Chine] ; Qi Zhao [République populaire de Chine]Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
000441 (2020) Henry Ji [États-Unis] ; Ying Yan [États-Unis] ; Beibei Ding [États-Unis] ; Wenzhong Guo [États-Unis] ; Mark Brunswick [États-Unis] ; Andreas Niethammer [États-Unis] ; Williams Soohoo [États-Unis] ; Robin Smith [États-Unis] ; Alexis Nahama [États-Unis] ; Yanliang Zhang [États-Unis]Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "against" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "against" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    against
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021